Study of Default Options in Advance Directives

Completed · Not applicable

Conditions studied: COPD, Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy, Idiopathic Pulmonary Fibrosis, Other Interstitial Lung Disease Without Curative Therapy, Congestive Heart Failure, NYHA Class IV or NYHA Class III Plus 1 Hospitalization in the Past Year, Malignancy, Any Stage 3B or 4 Solid Tumor

In brief

Default options represent the events or conditions that are set into place if no alternatives are actively chosen. The setting of default options has well-established effects on a broad range of human decisions, but its influence on patients' preferences for end-of-life care is only beginning to be understood. This is a 3-armed randomized clinical trial in Veterans at high risk for critical illness, assessing the impact of Advance Directive (AD) forms framed with different default options. The central goals are to assess how default options in ADs influence the end-of-life care choices made by patients at risk for critical care, and these patients' hospital and ICU utilization. The investigators hypothesize that setting defaults in real ADs will increase the proportion of Veterans selecting comfort-oriented plans of care, decrease selections of life-extending therapies such as mechanical ventilation and dialysis, and reduce the proportion of time during follow-up that Veterans spend in the hospital and/or ICU, without affecting patient satisfaction with end-of-life care planning.

Key facts

Study ID

NCT01817686

Run by

Corporal Michael J. Crescenz VA Medical Center

People needed

62

Starts

2013-03-01

Expected to finish

2015-06-01

Last updated by the study team

2015-06-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Chronic Obstructive Pulmonary Disease (COPD) with severe or very severe airflow obstruction on pulmonary function testing and or receiving or eligible to receive long-term oxygen therapy AND/OR
• Idiopathic Pulmonary Fibrosis (IPF) AND/OR
• Other interstitial lung disease without curative therapy AND/OR
• Any stage 3B or 4 solid tumor AND/OR
• Congestive Heart Failure (CHF) either New York Heart Association NYHA) class IV or NYHA class III plus 1 hospitalization in the past year
• No previously signed advance directive in the medical record
• Neither listed for nor considering lung or heart transplantation
• High anticipated risk for critical illness in the next 2 years based on clinical judgment
• Interest in thinking about filling out an Advance Directive

You may not qualify if…

• Diseases for which life-extending medical therapies may be available
• Inability to speak and/or read English proficiently
• New clinic patients meeting the clinic provider for the first time
• Patients being actively evaluated or already listed for transplants
• Patients already having an AD
• Cognitive impairment necessitating proxy consent

Where it is running

• Philadelphia Veterans Affairs Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.